SCHEMBL29567155

SCHEMBL29567155

Cc1ccccc1-c1nc(NS(=O)(=O)c2cnn(C)c2)nc(O)c1C(F)(F)C(F)(F)F

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 3/20 0.35
▸ HTR7 P34969 3/20 0.35
▸ PTGS2 P35354 2/20 0.34
▸ PTGS1 P23219 1/20 0.34
▸ EGFR P00533 2/20 0.33
▸ FGFR1 P11362 2/20 0.33
▸ KDR P35968 2/20 0.33
▸ BRAF P15056 1/20 0.33
▸ BRD4 O60885 1/20 0.33
▸ PIK3CG P48736 3/20 0.33
▸ PIK3CD O00329 2/20 0.33
▸ PIK3CB P42338 2/20 0.33
▸ PIK3CA P42336 1/20 0.33
▸ MTOR P42345 1/20 0.33
▸ CCNE2 O96020 1/20 0.33
▸ CCNE1 P24864 1/20 0.33
▸ CDK2 P24941 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ RXFP1 Q9HBX9 1/20 0.33
▸ PCK1 P35558 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29566874 0.94 HTR1A (0.39) HTR1AHTR7PTGS2PTGS1EGFR
SCHEMBL24309502 0.89 HTR1A (0.35) HTR1AHTR7PTGS2PTGS1BRAF
SCHEMBL24310083 0.86 HTR1A (0.39) HTR1AHTR7PTGS2PTGS1BRAF
SCHEMBL24309608 0.82 HTR1A (0.36) HTR1AHTR7PTGS2PTGS1BRAF
SCHEMBL24309547 0.80 HTR1A (0.37) HTR1AHTR7BRAFBRD4PIK3CG
SCHEMBL29566455 0.80 HTR1A (0.37) HTR1AHTR7BRAFBRD4PIK3CG
SCHEMBL24310673 0.80 HTR1A (0.40) HTR1AHTR7PTGS2PTGS1BRAF
SCHEMBL24309875 0.79 HTR1A (0.39) HTR1AHTR7EGFRFGFR1KDR
SCHEMBL29566963 0.79 RAD52 (0.36) HTR1AHTR7BRD4KDM4EJAK1
SCHEMBL24309497 0.79 HTR1A (0.40) HTR1AHTR7PTGS2PTGS1EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback